Literature DB >> 24555621

Apparent diffusion coefficient for prostate cancer imaging: impact of B values.

Yahui Peng1, Yulei Jiang, Tatjana Antic, Ila Sethi, Christine Schmid-Tannwald, Scott Eggener, Aytekin Oto.   

Abstract

OBJECTIVE: The purpose of this article is to investigate the effect of b values on apparent diffusion coefficient (ADC) values estimated from 1.5-T diffusion-weighted MRI (DWI) of the prostate acquired with an endorectal coil in distinguishing prostate cancer from normal-tissue regions of interest (ROIs) and the correlation of ADC values with the tumor Gleason score.
MATERIALS AND METHODS: Pretreatment DWI studies were analyzed retrospectively in 51 consecutive patients with prostate cancer with either two (b=0 and 1000 s/mm2; n=26 patients) or five (b=0, 50, 200, 1500, and 2000 s/mm2; n=25 patients) b values. In 45 normal peripheral-zone ROIs and 65 prostate cancer ROIs (14 in the central gland), ADC values were estimated by use of several combinations of two or five b values and a monoexponential model. We used the area under the receiver operating characteristic curve to characterize the effectiveness of ADC values in distinguishing prostate cancer from normal-tissue ROIs, and we calculated Spearman rank-order correlation between ADC values and the Gleason score.
RESULTS: ADC values were often significantly different (p<0.001) when estimated from different combinations of two or five b values. However, except when both b values were less than or equal to 200 mm2/s or greater than or equal to 1500 mm2/s, the AUC value for distinguishing prostate cancer from normal-tissue ROIs was similar (0.88-0.93). The correlation coefficients between ADC values and the Gleason score were between -0.30 and -0.68.
CONCLUSION: The choice of b values can significantly affect ADC estimates. ADC values can produce a similar discriminant performance in distinguishing prostate cancer from normal-tissue ROIs and in correlation with the Gleason score, but an appropriate ADC cutoff value needs to be selected specifically for each b-value combination.

Entities:  

Mesh:

Year:  2014        PMID: 24555621     DOI: 10.2214/AJR.13.10917

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  New prostate MRI techniques and sequences.

Authors:  Aritrick Chatterjee; Carla Harmath; Aytekin Oto
Journal:  Abdom Radiol (NY)       Date:  2020-12

2.  Estimation of optimal b-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer.

Authors:  Kishor Karki; Geoffrey D Hugo; John C Ford; Kathryn M Olsen; Siddharth Saraiya; Robert Groves; Elisabeth Weiss
Journal:  Phys Med Biol       Date:  2015-09-25       Impact factor: 3.609

Review 3.  The expanding landscape of diffusion-weighted MRI in prostate cancer.

Authors:  Andreas G Wibmer; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2016-05

Review 4.  Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility.

Authors:  Maysam M Jafar; Arman Parsai; Marc E Miquel
Journal:  World J Radiol       Date:  2016-01-28

5.  Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.

Authors:  Sarah L Hurrell; Sean D McGarry; Amy Kaczmarowski; Kenneth A Iczkowski; Kenneth Jacobsohn; Mark D Hohenwalter; William A Hall; William A See; Anjishnu Banerjee; David K Charles; Marja T Nevalainen; Alexander C Mackinnon; Peter S LaViolette
Journal:  J Med Imaging (Bellingham)       Date:  2017-10-27

6.  The diagnostic accuracy of high b-value diffusion- and T2-weighted imaging for the detection of prostate cancer: a meta-analysis.

Authors:  Tom J Syer; Keith C Godley; Donnie Cameron; Paul N Malcolm
Journal:  Abdom Radiol (NY)       Date:  2018-07

7.  Calculation of Apparent Diffusion Coefficients in Prostate Cancer Using Deep Learning Algorithms: A Pilot Study.

Authors:  Lei Hu; Da Wei Zhou; Cai Xia Fu; Thomas Benkert; Yun Feng Xiao; Li Ming Wei; Jun Gong Zhao
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

8.  Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer.

Authors:  Sean D McGarry; John D Bukowy; Kenneth A Iczkowski; Allison K Lowman; Michael Brehler; Samuel Bobholz; Andrew Nencka; Alex Barrington; Kenneth Jacobsohn; Jackson Unteriner; Petar Duvnjak; Michael Griffin; Mark Hohenwalter; Tucker Keuter; Wei Huang; Tatjana Antic; Gladell Paner; Watchareepohn Palangmonthip; Anjishnu Banerjee; Peter S LaViolette
Journal:  J Med Imaging (Bellingham)       Date:  2020-09-09

9.  VERDICT-AMICO: Ultrafast fitting algorithm for non-invasive prostate microstructure characterization.

Authors:  Elisenda Bonet-Carne; Edward Johnston; Alessandro Daducci; Joseph G Jacobs; Alex Freeman; David Atkinson; David J Hawkes; Shonit Punwani; Daniel C Alexander; Eleftheria Panagiotaki
Journal:  NMR Biomed       Date:  2018-10-31       Impact factor: 4.044

10.  Synthetic Apparent Diffusion Coefficient for High b-Value Diffusion-Weighted MRI in Prostate.

Authors:  Prativa Sahoo; Russell C Rockne; Alexander Jung; Pradeep K Gupta; Ram K S Rathore; Rakesh K Gupta
Journal:  Prostate Cancer       Date:  2020-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.